NCT05465551

Brief Summary

The purpose of this study is to develop a prototype of a home-based, dyadic tangible toolkit comprised of simple tools to help people living with dementia (PLWD) and their care partners manage stress at home. A human-centered design approach will be used to develop and user-test a prototype of a dyadic, tangible stress-management toolkit with and for PLWD and their care partners; and to explore the feasibility of collecting several stress-related outcomes. A total of 4 focus groups (n=3-4 dyads/group) will be convened to explore the experiences, perceptions, preferences, and recommendations of dementia-caring dyads regarding stress, stress management, and key components and features of a stress management toolkit. Eligible tools for the toolkit include low burden, high safety tools such as weighted blankets, robotic pets and baby dolls, guided journals, aromatherapy and bright light therapy devices, and massage and acupressure tools. Ten dyads who were not involved in prototype development will then use the toolkit for 2 weeks. Feedback on usability, feasibility, and acceptability will be collected through questionnaires (end of weeks 1 and 2) and 3 focus groups (3-4 dyads/group at end of week 2). We will collect stress-related, participant-reported outcomes (e.g., neuropsychiatric symptoms of dementia, caregiver stress, dyadic relationship strain), and saliva biospecimens from participants with dementia and their care partners at baseline and end of week 2, to explore their utility as endpoints in a future toolkit intervention that uses a single-arm, pre-post study design. Results will yield valuable data to support development and preliminary testing of a stress management toolkit intervention in a future pilot study. This study involves human subjects and is expected to yield no more than minimal risk. Tools eligible for the toolkit must have demonstrated high degrees of safety in prior research. Major risks for participation include the potential for negative emotional responses to focus group discussions and surveys pertaining to stress, excess time burden to participate in the study, and breach of confidentiality. It is not anticipated, but there is a potential for physical discomfort if tools are not used as directed, which is why the toolkits will include a user guide outlining safety information, which a research team member will review with each participant prior to use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 20, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

December 20, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2025

Completed
Last Updated

March 7, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

June 27, 2022

Last Update Submit

March 6, 2025

Conditions

Keywords

Nonpharmacological interventions

Outcome Measures

Primary Outcomes (7)

  • Frequency of toolkit use

    Number of days toolkit was used over the last week (range 0-7) will be assessed among participants enrolled in user-testing arm.

    End of week 1 of user-testing period

  • Frequency of toolkit use

    Number of days toolkit was used over the last week (range 0-7) will be assessed among participants enrolled in user-testing arm.

    End of week 2 of user-testing period

  • Enrollment rate

    Percentage of participant dyads enrolled/dyads screened in user-testing arm.

    Through study completion, an average of 1 year

  • Withdrawal rate

    Percentage of dyads that withdraw/dyads enrolled in user-testing arm.

    Through study completion, an average of 1 year

  • Frequency of adverse events and injuries

    Number of adverse events and injuries reported in user-testing arm.

    Through study completion, an average of 1 year

  • Participant satisfaction with toolkit, as assessed using a toolkit satisfaction scale

    Investigator developed multi-item satisfaction scale will include Likert-scaled items pertaining to satisfaction with design and delivery of the toolkit among participants in the user-testing arm; item ranges 1=not satisfied at all to 5 very satisfied). Scores will be averaged to yield and overall satisfaction score with higher scores indicating a greater degree of satisfaction.

    Within 1 week after user-testing period

  • Participant perceived benefit with toolkit, as assessed using a toolkit benefit scale

    Investigator developed multi-item benefit scale will include Likert-scaled items pertaining to perceived benefit from the toolkit among participants in the user-testing arm; item ranges 1=not beneficial at all to 5 very beneficial). Scores will be averaged to yield and overall benefit score with higher scores indicating a greater degree of benefit.

    Within 1 week after user-testing period

Secondary Outcomes (8)

  • Percentage of participant completion of neuropsychiatric symptoms of dementia outcome measure, as assessed using the Neuropsychiatric Inventory-Questionnaire

    Baseline, pre user-testing period

  • Percentage of participant completion of neuropsychiatric symptoms of dementia outcome measure, as assessed using the Neuropsychiatric Inventory-Questionnaire

    Within 1 week after user-testing period

  • Percentage of participant completion of caregiver stress outcome measure, as assessed using the Perceived Stress Scale

    Baseline, pre user-testing period

  • Percentage of participant completion of caregiver stress outcome measure, as assessed using the Perceived Stress Scale

    Within 1 week after user-testing period

  • Percentage of participant completion of dyadic relationship strain outcome measure, as assessed using the Dyadic Relationship Scale

    Baseline, pre user-testing period

  • +3 more secondary outcomes

Study Arms (2)

Stress Management Toolkit Prototype Development

NO INTERVENTION

3-4 qualitative focus groups (n=3-4 dyads/group) will be held to explore experiences, perceptions, preferences, and recommendations of dementia-caring dyads regarding stress, stress management, and key components and features of a stress management toolkit. Eligible tools for the toolkit include low burden, high safety tools (e.g., weighted blankets, robotic pets and baby dolls, guided journals, aromatherapy, bright light therapy devices, massage and acupressure tools).

Stress Management Toolkit Prototype User Testing

EXPERIMENTAL

10 dyads will use the toolkit for 2 weeks in their own homes. Feedback on usability, feasibility, and acceptability will be collected through questionnaires and focus groups. Stress-related, participant-reported outcomes (e.g., neuropsychiatric symptoms of dementia, caregiver stress, dyadic relationship strain), and salivary cortisol biospecimens will be collected at baseline and end of week 2, to explore their utility as endpoints in a future pilot study to examine efficacy.

Combination Product: Stress Management Toolkit

Interventions

Stress Management ToolkitCOMBINATION_PRODUCT

The toolkit will be a home-based, dyadic tangible toolkit comprised of simple tools to help people living with dementia (PLWD) and their care partners manage stress at home. Potential tools for the toolkit includes low burden, high safety tools such as weighted blankets, robotic pets and baby dolls, guided journals, aromatherapy and bright light therapy devices, and massage and acupressure tools. The tookit will also include user-safety guidelines and directions on how to use each tool. Tools will be included for participants with dementia and care partners.

Stress Management Toolkit Prototype User Testing

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 60 years and over with a diagnosis of dementia of any type
  • able to express self verbally
  • English speaking.

You may not qualify if:

  • has a hearing or visual impairment that limits their ability to participate in the screening process or to participate in a focus group.
  • age 21 years and older
  • identify as a primary care partner of someone with dementia
  • English speaking
  • has a hearing or visual impairment that limits their ability to participate in the screening process or to participate in a focus group.
  • Dyadic eligibility criteria include:
  • both the PLWD and care partner reside in the same household or personal residence in the community
  • dyad has lived together for at least 1 month
  • dyad has telephone or internet access
  • Dyads will be excluded if they reside in assisted living or other long-term care setting.
  • Dyads participating in user-testing phase will also be excluded if either member:
  • currently receives cytokine-based therapy
  • currently receives radiation therapy to the salivary glands or thyroid
  • are diagnosed with Cushing or Addison's disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Caregiver and dementia community support organizations

Durham, North Carolina, 27705, United States

Location

Related Publications (1)

  • Harris M, Van Houtven C, Hastings S. Development of a Home-Based Stress Management Toolkit for Dementia Caring Dyads: Protocol for a Pilot Intervention Development and Feasibility Study. JMIR Res Protoc. 2022 Dec 14;11(12):e43098. doi: 10.2196/43098.

MeSH Terms

Conditions

DementiaCaregiver Burden

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Melissa L Harris, PhD

    Duke University School of Nursing

    PRINCIPAL INVESTIGATOR
  • Susan N Hastings, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

July 20, 2022

Study Start

December 20, 2022

Primary Completion

January 6, 2025

Study Completion

January 6, 2025

Last Updated

March 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations